查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446523

美國動物用藥品市場規模、佔有率和趨勢分析報告：2024-2030年按產品類型、動物類型、給藥途徑、分銷管道和細分市場預測

U.S. Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國動物用藥品市場成長及趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，美國動物用藥品市場規模預計將達到218億美元，2024年至2030年複合年成長率預計為6.8%。

人畜共通感染疾病盛行率上升、牲畜數量增加、對預防性醫療保健的日益關注、寵物醫學的進步以及寵物擁有量的增加是推動市場成長的關鍵因素。根據美國寵物產品協會（APPA）2023年3月發布的報告，狗是美國最受歡迎的寵物，有6,510萬個家庭養狗。貓排名第二，有 4,650 萬戶，淡水魚排名第三，有 1,110 萬戶。

由於牲畜數量的顯著增加，通用和感染疾病呈上升趨勢。這導致人們更加重視預防性醫療措施，以維持牲畜健康和生產力。此外，技術進步透過增強診斷能力、治療選擇和醫療設備，提高動物照護質量，正在徹底改變獸醫學。

美國動物用藥品市場報告亮點

  • 按產品分類，由於研發投資增加以及醫療產業的進步，製藥業在 2023 年以 67.6% 的最大收益佔有率引領市場。
  • 按動物類型分類，由於人口成長和畜牧業全球化對動物蛋白的需求不斷增加，生產動物細分市場在 2023 年佔據最大收益佔有率，達到 58.5%。預計伴同性動物在預測期內將表現出最快的複合年成長率。
  • 從給藥途徑來看，注射劑預計將在2023 年佔據市場主導地位，而由於寵物擁有量的增加和對預防性醫療保健的關注，預計口服製劑在預測期內將以顯著的複合年成長率成長。
  • 按分銷管道分類，預計到 2023 年，獸醫院和診所將佔據大部分市場佔有率，而電子商務領域預計將在預測期內以最快的複合年成長率成長。
  • 2024年2月，默克宣布簽署最終協議，收購Elanco的水生動物業務，其中包括水生動物藥物和疫苗、食品和補充品的創新產品組合。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章美國動物用藥品市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國動物用藥品市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國動物用藥品市場：產品預估及趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 美國動物用藥品市場按產品前景
  • 2018年至2030年市場規模、預測與趨勢分析

第5章美國動物用藥品市場：動物種類估算及趨勢分析

  • 2023 年和 2030 年動物類型市場佔有率
  • 細分儀表板
  • 按動物類型分類的美國動物用藥品市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第6章美國動物用藥品市場：給藥途徑預估及趨勢分析

  • 2023 年及 2030 年給藥途徑市場佔有率
  • 細分儀表板
  • 按給藥途徑分類的美國動物用藥品市場前景
  • 2018年至2030年市場規模、預測與趨勢分析

第7章美國動物用藥品市場：通路估算及趨勢分析

  • 2023 年及 2030 年分銷通路市場佔有率
  • 細分儀表板
  • 美國動物用藥品市場分佈前景
  • 2018年至2030年市場規模、預測與趨勢分析

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market heat map analysis, 2023
  • 公司簡介
    • Zoetis Services LLC
    • Boehringer Ingelheim International GmbH
    • Merck &Co., Inc.
    • Elanco
    • Ceva
    • Phibro Animal Health Corporation
    • Bimeda Corporate
    • IDEXX
    • Vetbiologics
    • Neogen Corporation
    • ADM
    • Kindred Biosciences, Inc.
    • Cargill, Incorporated
Product Code: GVR-4-68040-197-8

U.S. Veterinary Market Growth & Trends:

The U.S. veterinary medicine market size is anticipated to reach USD 21.80 billion by 2030 and is projected to grow at a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising incidence rates of zoonotic diseases, increased livestock population, growing focus on preventive care, advancements in pet medicine and increasing pet ownership are the major factors contributing to the market growth. According to the March 2023 report released by the American Pet Products Association (APPA), dogs are the most popular pets in the U.S., with 65.1 million households owning a dog. Cats come in second with 46.5 million households, followed by freshwater fish with 11.1 million households.

The livestock population has grown significantly, leading to an increase in zoonotic diseases and chronic diseases. This has led to a growing emphasis on preventive healthcare measures to maintain the health and productivity of animals. Moreover, advancements in technology have revolutionized veterinary medicine by enhancing diagnostic capabilities, treatment options, and medical devices, thereby improving the quality of animal care.

U.S. Veterinary Medicine Market Report Highlights:

  • Based on products, the pharmaceuticals segment led the market with the largest revenue share of 67.6% in 2023, owing to growing investments in research and development and advancements in the field of medicine
  • Based on the animal type, the production animals segment held the market with largest revenue share of 58.5% in 2023, due to an increasing demand for animal protein due to population growth and globalization of livestock production. Companion animals in animal type segment are anticipated to witness fastest CAGR over the forecast period
  • Based on route of administration, the injectable segment dominated the market in 2023 and oral segment is anticipated to witness a significant growth in CAGR over the forecast period, owing to an increasing pet ownership and focus on preventive healthcare
  • Based on distribution channel, the veterinary hospitals & clinics segment held the majority of the market share in 2023 and e-commerce segment is expected to grow at the fastest CAGR over forecast period
  • In February 2024, Merck & Co., Inc. announced the signing of a definitive agreement to acquire the aqua business of Elanco, which includes an innovative portfolio of medications and vaccines, food, and supplements for aquatic animals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal type
    • 1.2.3. Route of administration
    • 1.2.4. Distribution channel
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Animal type outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Distribution channel outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Veterinary Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing pet ownership
      • 3.2.1.2. Rising incidences of zoonotic diseases
      • 3.2.1.3. Advancements in pet medicine
      • 3.2.1.4. Growing focus on preventive care.
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
      • 3.2.2.2. Rising costs associated with animal healthcare
  • 3.3. U.S. Veterinary Medicine Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Veterinary Medicine Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Veterinary Medicine Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Biologics
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1.1. Vaccines
      • 4.4.1.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1.1.1.1. Modified/ Attenuated live
      • 4.4.1.1.1.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1.1.1.2. Inactivated (Killed)
      • 4.4.1.1.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1.1.1.3. Other vaccines
      • 4.4.1.1.1.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1.2. Other biologics
      • 4.4.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Pharmaceuticals
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.1.1. Parasiticides
      • 4.4.2.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.1.2. Anti-infectives
      • 4.4.2.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.1.3. Anti-inflammatory
      • 4.4.2.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.1.4. Analgesics
      • 4.4.2.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.1.5. Others
    • 4.4.3. Medicated feed additives
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Veterinary Medicine Market: Animal Type Estimates & Trend Analysis

  • 5.1. Animal Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Veterinary Medicine Market by Animal Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Production animals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.1.1. Poultry
      • 5.4.1.1.1.1. Market estimated and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.1.2. Pigs
      • 5.4.1.1.2.1. Market estimated and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.1.3. Cattle
      • 5.4.1.1.3.1. Market estimated and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.1.4. Sheep & goats
      • 5.4.1.1.4.1. Market estimated and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.1.5. Others
      • 5.4.1.1.5.1. Market estimated and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Companion animals
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.1.1. Dogs
      • 5.4.2.1.1.1. Market estimated and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.1.2. Cats
      • 5.4.2.1.2.1. Market estimated and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.1.3. Horses
      • 5.4.2.1.3.1. Market estimated and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.1.4. Others
      • 5.4.2.1.4.1. Market estimated and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Veterinary Medicine Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Route of administration Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Veterinary Medicine Market by Route of Administration Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Oral
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Injectable
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.3. Topical
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.4. Other routes
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)

Chapter 7. U.S. Veterinary Medicine Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Distribution Channel Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Veterinary Medicine Market by Distribution Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Veterinary hospitals & clinics
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. E-commerce
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.3. Offline retail stores
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Zoetis Services LLC
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Boehringer Ingelheim International GmbH
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merck & Co., Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Elanco
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Ceva
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Phibro Animal Health Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Bimeda Corporate
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. IDEXX
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Vetbiologics
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Neogen Corporation
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. ADM
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Kindred Biosciences, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Cargill, Incorporated
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. veterinary medicine market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. veterinary medicine market, by animal type, 2018 - 2030 (USD Million)
  • Table 4 U.S. veterinary medicine market, by route of administration, 2018 - 2030 (USD Million)
  • Table 5 U.S. veterinary medicine market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Veterinary medicine market: market outlook
  • Fig. 10 U.S. Veterinary medicine competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. Veterinary medicine market driver impact
  • Fig. 16 U.S. Veterinary medicine market restraint impact
  • Fig. 17 U.S. Veterinary medicine market strategic initiatives analysis
  • Fig. 18 U.S. Veterinary medicine market: Product outlook and key takeaways
  • Fig. 19 Biologics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Modified/ Attenuated live market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Inactivated (Killed) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Other vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Other biologics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Parasiticides market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Anti-infectives market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Anti-inflammatory market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Analgesics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Medicated feed additives market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Veterinary medicine market: Animal type movement analysis
  • Fig. 33 U.S. Veterinary medicine market: Animal type outlook and key takeaways
  • Fig. 34 Production animals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Poultry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Pigs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Cattle market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Sheep & goats market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Companion animals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Dogs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Cats market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Horses market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Veterinary medicine Market: Product movement Analysis
  • Fig. 46 U.S. Veterinary medicine market: Route of administration movement analysis
  • Fig. 47 U.S. Veterinary medicine market: Route of administration outlook and key takeaways
  • Fig. 48 Oral market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Topical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Other routes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. Veterinary medicine market: Distribution channel movement analysis
  • Fig. 53 U.S. Veterinary medicine market: Distribution channel outlook and key takeaways
  • Fig. 54 U.S. Veterinary hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 E-commerce market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Offline retail stores market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Market share of key market players- U.S. Veterinary medicine market